SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michael L. Reed, Kristina M. Fanning, Daniel Serrano, Dawn C. Buse, Richard B. Lipton, Persistent Frequent Nausea Is Associated With Progression to Chronic Migraine: AMPP Study Results, Headache: The Journal of Head and Face Pain, 2014, 54, 10
  2. 2
    D. Borsook, N. Erpelding, A. Lebel, C. Linnman, R. Veggeberg, P.E. Grant, C. Buettner, L. Becerra, R. Burstein, Sex and the migraine brain, Neurobiology of Disease, 2014, 68, 200

    CrossRef

  3. 3
    Michail Vikelis, Dimos D Mitsikostas, Alan M Rapoport, Sumatriptan iontophoretic transdermal system for the acute treatment of migraine, Pain Management, 2014, 4, 2, 123

    CrossRef

  4. 4
    Kappa P. Meadows, Mark Pierce, Carol O'Neill, Sue Foster, Carter Jennings, Sumatriptan Transdermal System Can Be Correctly Assembled and Applied During Migraine Attacks, Headache: The Journal of Head and Face Pain, 2014, 54, 5
  5. 5
    Stephen D. Silberstein, Practical Management of Pain, 2014,

    CrossRef

  6. 6
    Yang Won Min, Jin Hee Lee, Byung-Hoon Min, Jun Haeng Lee, Jae J Kim, Chin-Sang Chung, Poong-Lyul Rhee, Clinical Predictors for Migraine in Patients Presenting With Nausea and/or Vomiting, Journal of Neurogastroenterology and Motility, 2013, 19, 4, 516

    CrossRef

  7. 7
    S. D. Silberstein, L. C. Newman, M. J. Marmura, S. J. Nahas, S. J. Farr, Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain, Current Medical Research and Opinion, 2013, 29, 7, 861

    CrossRef

  8. 8
    S D Silberstein, Emerging Target-Based Paradigms to Prevent and Treat Migraine, Clinical Pharmacology & Therapeutics, 2013, 93, 1, 78

    CrossRef

  9. 9
    Richard B. Lipton, Dawn C. Buse, Jane Saiers, Kristina M. Fanning, Daniel Serrano, Michael L. Reed, Frequency and Burden of Headache-Related Nausea: Results From the American Migraine Prevalence and Prevention (AMPP) Study, Headache: The Journal of Head and Face Pain, 2013, 53, 1
  10. You have free access to this content10
    Stephen Silberstein, Gastrointestinal Manifestations of Migraine: Meeting the Treatment Challenges, Headache: The Journal of Head and Face Pain, 2013, 53,
  11. 11
    Richard B. Lipton, Dawn C. Buse, Jane Saiers, Daniel Serrano, Michael L. Reed, Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study, Journal of Medical Economics, 2013, 16, 4, 490

    CrossRef

  12. You have free access to this content12
    Mark Pierce, Carol O'Neill, Ezra Felker, Terri Sebree, Sumatriptan Iontophoretic Transdermal System: History, Study Results, and Use in Clinical Practice, Headache: The Journal of Head and Face Pain, 2013, 53,
  13. 13
    Nu Cindy Chai, Robert E. Shapiro, Alan M. Rapoport, Why Does Vomiting Stop a Migraine Attack?, Current Pain and Headache Reports, 2013, 17, 9

    CrossRef

  14. You have free access to this content14
    Lawrence C. Newman, Why Triptan Treatment Can Fail: Focus on Gastrointestinal Manifestations of Migraine, Headache: The Journal of Head and Face Pain, 2013, 53,
  15. 15
    Jerome Goldstein, Timothy R. Smith, Neil Pugach, Jim Griesser, Terri Sebree, Mark Pierce, A Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine, Headache: The Journal of Head and Face Pain, 2012, 52, 9
  16. 16
    Gianni Allais, Sara Rolando, Ilaria Castagnoli Gabellari, Chiara Burzio, Gisella Airola, Paola Borgogno, Paola Schiapparelli, Rita Allais, Chiara Benedetto, Acupressure in the control of migraine-associated nausea, Neurological Sciences, 2012, 33, S1, 207

    CrossRef

  17. 17
    Archana Dixit, Manish Bhardwaj, Bhavna Sharma, Headache in Pregnancy: A Nuisance or a New Sense?, Obstetrics and Gynecology International, 2012, 2012, 1

    CrossRef

  18. 18
    Kathy Erlichson, Julie Waight, Therapeutic applications for subcutaneous triptans in the acute treatment of migraine, Current Medical Research and Opinion, 2012, 28, 7, 1231

    CrossRef

  19. 19
    Elliot A. Schulman, Transdermal Sumatriptan for Acute Treatment of Migraineurs With Baseline Nausea, Headache: The Journal of Head and Face Pain, 2012, 52, 2
  20. 20
    Timothy R. Smith, Jerome Goldstein, Richard Singer, Neil Pugach, Stephen Silberstein, Mark W. Pierce, Twelve-Month Tolerability and Efficacy Study of NP101, the Sumatriptan Iontophoretic Transdermal System, Headache: The Journal of Head and Face Pain, 2012, 52, 4
  21. 21
    Schwedt Todd J, Triptans for Migraine, 2012,

    CrossRef

  22. 22
    James E. Frampton, Needle-Free Subcutaneous Sumatriptan, CNS Drugs, 2011, 25, 11, 983

    CrossRef

  23. 23
    Michail Vikelis, Alan M Rapoport, New drug delivery options for migraine, Expert Review of Neurotherapeutics, 2011, 11, 6, 771

    CrossRef

  24. 24
    Natasha Mitchell, Catherine E Hewitt, Shalmini Jayakody, Muhammad Islam, Joy Adamson, Ian Watt, David J Torgerson, Randomised controlled trial of food elimination diet based on IgG antibodies for the prevention of migraine like headaches, Nutrition Journal, 2011, 10, 1, 85

    CrossRef

  25. 25
    Alan M. Rapoport, Fred Freitag, Starr H. Pearlman, The Authorsʼ Reply, CNS Drugs, 2011, 25, 2, 171

    CrossRef

  26. 26
    Alan M. Rapoport, Fred Freitag, Starr H. Pearlman, Innovative Delivery Systems for Migraine, CNS Drugs, 2010, 24, 11, 929

    CrossRef

  27. 27
    Mark W. Pierce, Transdermal delivery of sumatriptan for the treatment of acute migraine, Neurotherapeutics, 2010, 7, 2, 159

    CrossRef

  28. 28
    Rajeev Jain, Dwain L. Thiele, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  29. 29
    Marte Helene Bjørk, Lars J. Stovner, Morten Engstrøm, Marit Stjern, Knut Hagen, Trond Sand, Interictal quantitative EEG in migraine: a blinded controlled study, The Journal of Headache and Pain, 2009, 10, 5, 331

    CrossRef

  30. 30
    Wendy Golden, Judith K. Evans, Henry Hu, Migraine strikes study: factors in patients’ decision to treat early, The Journal of Headache and Pain, 2009, 10, 2, 93

    CrossRef

  31. You have free access to this content31
    Mark Pierce, Thomas Marbury, Carol O'Neill, Steven Siegel, Wei Du, Terri Sebree, Zelrix™: A Novel Transdermal Formulation of Sumatriptan, Headache: The Journal of Head and Face Pain, 2009, 49, 6
  32. 32
    Fred Freitag, Frederick R. Taylor, Mohammed A. Hamid, Anthony Rodgers, Carolyn M. Hustad, Karen E. Ramsey, Franck Skobieranda, Elimination of Migraine-Associated Nausea in Patients Treated with Rizatriptan Orally Disintegrating Tablet (ODT): A Randomized, Double-Blind, Placebo-Controlled Study, Headache: The Journal of Head and Face Pain, 2008, 48, 3
  33. 33
    Stephen D. Silberstein, Raj's Practical Management of Pain, 2008,

    CrossRef

  34. You have free access to this content34
    Daisy S. Ng-Mak, Roger Cady, Ya-Ting Chen, Larry Ma, Christopher F. Bell, X. Henry Hu, Can Migraineurs Accurately Identify Their Headaches as “Migraine” at Attack Onset?, Headache: The Journal of Head and Face Pain, 2007, 47, 5
  35. 35
    M. J. A. Láinez, J. Galván, J. Heras, C. Vila, Crossover, double-blind clinical trial comparing almotriptan and ergotamine plus caffeine for acute migraine therapy, European Journal of Neurology, 2007, 14, 3
  36. 36
    Frederick G. Freitag, Gary Finlayson, Alan M. Rapoport, Arthur H. Elkind, Merle L. Diamond, Jeffrey R. Unger, Alan C. Fisher, Robert B. Armstrong, Joseph F. Hulihan, Steven J. Greenberg, Effect of Pain Intensity and Time to Administration on Responsiveness to Almotriptan: Results from AXERT® 12.5 mg Time Versus Intensity Migraine Study (AIMS), Headache: The Journal of Head and Face Pain, 2007, 47, 4
  37. 37
    L Kelman, The triggers or precipitants of the acute migraine attack, Cephalalgia, 2007, 27, 5
  38. 38
    David W Dodick, Giorgio Sandrini, Paul Williams, Use of the Sustained Pain-Free Plus No Adverse Events Endpoint in Clinical Trials of Triptans in Acute Migraine, CNS Drugs, 2007, 21, 1, 73

    CrossRef

  39. 39
    Stephen D. Silberstein, William B. Young, Textbook of Clinical Neurology, 2007,

    CrossRef

  40. 40
    William Pryse-Phillips, Michel Aubé, Peter Bailey, Werner J. Becker, Andre Bellavance, Marek Gawel, Rose Giammarco, Gordon Mackie, R. Allan Purdy, Gordon Robinson, Gary Shapero, Keith Wilson, A Clinical Study of Migraine Evolution, Headache: The Journal of Head and Face Pain, 2006, 46, 10
  41. 41
    Jerome Goldstein, Stephen D. Silberstein, Joel R. Saper, Robert E. Ryan, Richard B. Lipton, Acetaminophen, Aspirin, and Caffeine in Combination Versus Ibuprofen for Acute Migraine: Results From a Multicenter, Double-Blind, Randomized, Parallel-Group, Single-Dose, Placebo-Controlled Study, Headache: The Journal of Head and Face Pain, 2006, 46, 3
  42. 42
    Shahram N. Malik, Mary Hopkins, William B. Young, Stephen D. Silberstein, Acute Migraine Treatment: Patterns of Use and Satisfaction in a Clinical Population, Headache: The Journal of Head and Face Pain, 2006, 46, 5
  43. 43
    Thomas W. Weiss, Deborah T. Gold, Stuart L. Silverman, Colleen A. McHorney, An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study*, Current Medical Research and Opinion, 2006, 22, 5, 949

    CrossRef

  44. 44
    FG Pradel, P Subedi, AA Varghese, CD Mullins, KA Weis, Does earlier headache response equate to earlier return to functioning in patients suffering from migraine?, Cephalalgia, 2006, 26, 4
  45. 45
    A. Ducros, Migraine, EMC - Neurologie, 2006, 3, 1, 1

    CrossRef

  46. 46
    MJA Láinez, S Evers, E Kinge, G Allais, C Allen, NA Rao, R Massaad, K Lis, Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine, Cephalalgia, 2006, 26, 3
  47. 47
    A. J. DOWSON, N. T. MATHEW, J. PASCUAL, Review of clinical trials using early acute intervention with oral triptans for migraine management, International Journal of Clinical Practice, 2006, 60, 6
  48. 48
    Richard Sadovsky, David W. Dodick, Identifying migraine in primary care settings, The American Journal of Medicine Supplements, 2005, 118, 11

    CrossRef

  49. 49
    Elizabeth Loder, Frederick G. Freitag, James Adelman, Starr Pearlman, Susan Abu-Shakra, Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo-controlled trial*, Current Medical Research and Opinion, 2005, 21, 3, 381

    CrossRef

  50. 50
    J. Schoenen, J. Pascual, S. Rasmussen, W. Sun, C. Sikes, J. Hettiarachchi, Patient preference for eletriptan 80 mg versus subcutaneous sumatriptan 6 mg: results of a crossover study in patients who have recently used subcutaneous sumatriptan, European Journal of Neurology, 2005, 12, 2
  51. 51
    J Scholpp, R Schellenberg, B Moeckesch, N Banik, Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan, Cephalalgia, 2004, 24, 11
  52. 52
    Stephen D. Silberstein, Headaches in pregnancy, Neurologic Clinics, 2004, 22, 4, 727

    CrossRef

  53. 53
    Stephen D Silberstein, Migraine, The Lancet, 2004, 363, 9406, 381

    CrossRef

  54. 54
    Jae Won Yoon, Dong Eon Moon, So Young Yang, Chong Min Park, Therapeutic Effect of the Patients with Chronic Migraine in Pain Clinic, The Korean Journal of Pain, 2004, 17, 2, 146

    CrossRef

  55. 55
    Roger K. Cady, Curtis P. Schreiber, Kathleen U. Farmer, Understanding the Patient With Migraine: The Evolution From Episodic Headache to Chronic Neurologic Disease. A Proposed Classification of Patients With Headache, Headache: The Journal of Head and Face Pain, 2004, 44, 5
  56. 56
    TJ Steiner, H-C Diener, EA MacGregor, J Schoenen, N Muirhead, CR Sikes, Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine, Cephalalgia, 2003, 23, 10
  57. 57
    Jonathan Paul Gladstone, Marek Gawel, Newer Formulations of the Triptans, Drugs, 2003, 63, 21, 2285

    CrossRef

  58. 58
    U Reuter, M Sanchez del Rio, JA Carpay, CJ Boes, SD Silberstein, Placebo adverse events in headache trials: headache as an adverse event of placebo, Cephalalgia, 2003, 23, 7
  59. 59
    Dara Jamieson, F. Michael Cutrer, Jerome Goldstein, Jeffrey Dayno, X. Henry Hu, On Behalf Of The USMAP Investigators, Real-World Experiences in Migraine Therapy With Rizatriptan, Headache: The Journal of Head and Face Pain, 2003, 43, 3
  60. 60
    Alan M. Rapoport, Marcelo E. Bigal, The clinical spectrum of migraine, Comprehensive Therapy, 2003, 29, 1, 35

    CrossRef

  61. 61
    Stephen D Silberstein, Topiramate in migraine prevention, Expert Review of Neurotherapeutics, 2003, 3, 6, 761

    CrossRef

  62. 62
    Stephen D. Silberstein, Encyclopedia of the Neurological Sciences, 2003,

    CrossRef

  63. 63
    William Pryse-Phillips, Michel Aubé, Marek Gawel, Robert Nelson, Allan Purdy, Keith Wilson, A Headache Diagnosis Project, Headache: The Journal of Head and Face Pain, 2002, 42, 8
  64. 64
    Roger Cady, Almotriptan Reduces the Incidence of Migraine-Associated Symptoms: A Pooled Analysis, Headache: The Journal of Head and Face Pain, 2002, 42,
  65. 65
    Nabih M. Ramadan, Assessing the Efficacy of Drugs for the Acute Treatment of Migraine, CNS Drugs, 2002, 16, 3, 181

    CrossRef

  66. 66
    Fred D. Sheftell, Communicating the Right Therapy for the Right Patient at the Right Time: Acute Therapy, The Canadian Journal of Neurological Sciences, 2002, 29, S2, S33

    CrossRef

  67. 67
    James U. Adelman, Leon C. Adelman, Randal Von Seggern, Cost-Effectiveness of Antiepileptic Drugs in Migraine Prophylaxis, Headache: The Journal of Head and Face Pain, 2002, 42, 10
  68. 68
    Gerhard Andersson, Nina Lindvall, Timo Hursti, Per Carlbring, Gerhard Andersson, Hypersensitivity to sound (hyperacusis): a prevalence study conducted via the internet and post: Hipersensibilidad al sonido (hiperacusia): un estudio de prevalencia realizado por internet y por correo, International Journal of Audiology, 2002, 41, 8, 545

    CrossRef

  69. 69
    Fred D. Sheftell, Stewart J. Tepper, New Paradigms in the Recognition and Acute Treatment of Migraine, Headache: The Journal of Head and Face Pain, 2002, 42, 1
  70. 70
    Bruce Charlesworth, Andrew J Dowson, Review of zolmitriptan and its clinical applications in migraine, Expert Opinion on Pharmacotherapy, 2002, 3, 7, 993

    CrossRef

  71. 71
    Sebastiaan Overeem, Jorine A van Vliet, Gert J Lammers, Frans G Zitman, Dick F Swaab, Michel D Ferrari, The hypothalamus in episodic brain disorders, The Lancet Neurology, 2002, 1, 7, 437

    CrossRef

  72. 72
    P Barbanti, G Fabbrini, M Pesare, N Vanacore, R Cerbo, Unilateral cranial autonomic symptoms in migraine, Cephalalgia, 2002, 22, 4
  73. 73
    Richard Peatfield, Migrainous features in cluster headache, Current Pain and Headache Reports, 2001, 5, 1, 67

    CrossRef

  74. 74
    Abdelmalik Slassi, Methvin Isaac, Jalaj Arora, Novel serotonergic and non-serotonergic migraine headache therapies, Expert Opinion on Therapeutic Patents, 2001, 11, 4, 625

    CrossRef

  75. 75
    Elizabeth Loder, Jan Lewis Brandes, Stephen Silberstein, Franck Skobieranda, Norman Bohidar, Lixia Wang, Denise Boyle, Andrea Kolodny, Filippa Guerra, Nancy Santanello, Lisa Johnson-Pratt, Preference Comparison of Rizatriptan ODT 10-mg and Sumatriptan 50-mg Tablet in Migraine, Headache: The Journal of Head and Face Pain, 2001, 41, 8
  76. 76
    William Pryse-Phillips, The Role of the Patient in Maximizing Efficacy of Drug Therapy in Migraine, Disease Management and Health Outcomes, 2001, 9, 4, 187

    CrossRef

  77. 77
    R. Michael Gallagher, George Dennish, Egilius L.H. Spierings, Rohini Chitra, A Comparative Trial of Zolmitriptan and Sumatriptan for the Acute Oral Treatment of Migraine, Headache: The Journal of Head and Face Pain, 2000, 40, 2
  78. 78
    Fd Sheftell, Aw Fox, Acute migraine treatment outcome measures: a clinician's view, Cephalalgia, 2000, 20,
  79. 79
    Robert E. Ryan, Seymour Diamond, Rose A. Giammarco, Sheena K. Aurora, Ronald C. Reed, Pamela E. Fletcher, Efficacy of Zolmitriptan at Early Time-Points for the Acute Treatment of Migraine and Treatment of Recurrence, CNS Drugs, 2000, 13, 3, 215

    CrossRef

  80. 80
    K Grosser, R Oelkers, T Hummel, G Geisslinger, K Brune, G Kobal, J Lotsch, Olfactory and trigeminal event-related potentials in migraine, Cephalalgia, 2000, 20, 7, 621

    CrossRef

  81. 81
    Alan Main, Ioannis Vlachonikolis, Andrew Dowson, The Wavelength of Light Causing Photophobia in Migraine and Tension-type Headache Between Attacks, Headache: The Journal of Head and Face Pain, 2000, 40, 3
  82. 82
    STEPHEN D. SILBERSTEIN, Menstrual Migraine, Journal of Women's Health & Gender-Based Medicine, 1999, 8, 7, 919

    CrossRef

  83. 83
    Giorgio Sandrini, Giuseppe Nappi, Primary headaches: Diagnosis and treatment, Current Review of Pain, 1999, 3, 2, 100

    CrossRef

  84. 84
    Carl G.H. Dahlof, Alan M. Rapoport, Fred D. Sheftell, Christopher R. Lines, Rizatriptan in the treatment of migraine, Clinical Therapeutics, 1999, 21, 11, 1823

    CrossRef

  85. 85
    Carl Dahlof, Christopher Lines, Rizatriptan: a new 5-HT1B/1D receptor agonist for the treatment of migraine, Expert Opinion on Investigational Drugs, 1999, 8, 5, 671

    CrossRef

  86. 86
    David L. McMillin, Douglas G. Richards, Eric A. Mein, Carl D. Nelson, The Abdominal Brain and Enteric Nervous System, The Journal of Alternative and Complementary Medicine, 1999, 5, 6, 575

    CrossRef

  87. 87
    Stephen D Silberstein, Headache, eLS,
  88. 88
    Stephen D Silberstein, Headache, eLS,
  89. 89
    References,